8.512.63% ( -0.23 )
Delay Closed: Nov 13, 15:00:00Valuation
Current ValuationThe current P/E ratio is 41.12, above the reasonable range, cheaper than 5.14% of the time in the past 5 years, and the industry ranks 16/27, the industry Median 12.74.
41.12xP/E
¥8.51Stock price
¥0.21Earnings per share
41.12xP/E
Stock price¥8.51Earnings per share¥0.21
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 29.57x
- Typical range
- 18.89x–32.55x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 12.74x
011223344
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 12.74x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
301015SZBaheal Pharma | 55.38x | 22.47% | ¥13.17B |
600056SHChina Meheco | 41.12x | -- | ¥12.73B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
